BioSpace News Archive

Bio NC

Cancer Advances, Inc. announces new publication: “Gastrin Vaccine Improves Response to Immune Checkpoint Antibody in Murine Pancreatic Cancer by Altering the Tumor Microenvironment”, in the journal Cancer Immunology, Immunotherapy

Inactivation of the growth peptide gastrin modulates the tumor microenvironment of pancreatic cancer rendering it more susceptible to immune checkpoint antibody therapy.

November 11, 2019
·
4 min read
Business

IRRAS Announces Addition of Dr. Coenraad Tamse as Vice President, International Sales

IRRAS, a global healthcare company with a comprehensive portfolio of innovative products for neurocritical care, announced the hiring of Dr. Coenraad Tamse as Vice President, International Sales.

November 11, 2019
·
3 min read
Bio NC

Cancer Advances, Inc. announces a new publication “Vaccine Against Gastrin, a Polyclonal Antibody Stimulator, Decreases Pancreatic Cancer Metastases” in the American Journal of Physiology—Gastrointestinal and Liver Physiology

Immune competent female mice with pancreatic cancer treated with Polyclonal Antibody Stimulator (PAS) vaccine had significantly smaller tumors and fewer metastases than control mice.

November 11, 2019
·
4 min read
TTP plc Desktop Biology Enables Development and Manufacture of DnaNudge Technology

Novel multiplex technology developed to help consumers make healthier choices based on their genetic profile

November 11, 2019
·
3 min read
Business

Foamix Reports Third Quarter 2019 Financial Results and Provides Corporate Update

Foamix Pharmaceuticals Ltd., a specialty pharmaceutical company focused on developing and commercializing proprietary topical therapies to address unmet needs in dermatology, announced financial results for the three and nine months ended September 30, 2019 and provided a corporate update.

November 11, 2019
·
15 min read
Drug Development

Cerecor Announces Clinical Updates on CERC-301 and CERC-802

Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company focused on becoming a leader in development and commercialization of treatments for orphan diseases and neurology, announced today that it has achieved significant milestones in its clinical development programs.

November 11, 2019
·
12 min read
Job Trends

Myriad’s Prequel™ Prenatal Screen Demonstrates High Performance Across All Fetal-Fraction Levels in Women Undergoing Noninvasive Prenatal Screening

Clinical Study Shows Prequel Delivers an Industry Leading Low Test Failure Rate of 0.1%

November 11, 2019
·
7 min read
Business

Neptune Reports Fiscal 2020 Second Quarter Results

Neptune Wellness Solutions Inc. (“Neptune” or the “Corporation”) (NASDAQ: NEPT) (TSX: NEPT), today announced its financial and operating results for the three-month period ended September 30, 2019.

November 11, 2019
·
22 min read
Zimmer Biomet Holdings to Present at Piper Jaffray’s 31st Annual Healthcare Conference

Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, will participate in the Piper Jaffray Annual Healthcare Conference at the Lotte New York Palace in New York City.

November 11, 2019
·
1 min read
Business

Compugen Reports Third Quarter 2019 Results

Compugen Ltd. (NASDAQ: CGEN), a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, today reported financial results for the third quarter ended September 30, 2019.

November 11, 2019
·
9 min read